About Us


CEO Greetings Mission / Core Value Our Brand Organization Certificates History

Klasia Vision

Our Brand

CEO Greetings

KLASIA has developed competitive products and commercially viable items through creative R&D planning and execution.

In the future, we will optimize our execution and planning capabilities at all stages of drug development, enhance our R&D capabilities to create competitive business opportunities, and strive to contribute to the health of humanity and the development of the pharmaceutical industry.

We will also strive to improve the business environment in the pharmaceutical industry by correcting some of the wrong business practices and ensuring that competent and hardworking companies are recognized.

We will continue to work hard to be remembered as a company that develops good products and is trusted by all domestic and overseas companies and people with whom we have a stake.

President  James Chun

Organization

Certificates

Certificates

Certificate of Excellent Technology Evaluation Company

Development of Medicines to Acquire Exclusivity

Certificate of Technical Achievement

IMD Research and Development Technology

INNOBIZ COMPANY

Certificate of Technology Inno-Biz

Certificate of Inno-Biz(EN)

Certificate of Venture Enterprise

Certificate of Venture Enterprise(EN)

Certificate of Department in Charge of R&D

Certificate of Authorization(EN)




Certificate of Patent

Certificate of Patent 10-2216470

Certificate of Patent 10-2481517




Licence

Drug Wholesale Dealer licence

Registration Document of The Import Business




Membership Cards

Certificate of Membership (Korea International Trade Association)




Award

The marquis who's who(EN)

Award Certificate for Outstanding Export Performance ($1-Million Export Tower)

Award Plaque for Outstanding Export Performance ($1-Million Export Tower)

Award Certificate for Outstanding Export Performance ($3-Million Export Tower)

Award Plaque for Outstanding Export Performance ($3-Million Export Tower)

Award Plaque for Service Area

History

2009 ~ 2010
Established Klasia Co., Ltd. (E&C Dream Tower, Gasan-dong, Geumcheon-gu, Seoul)
Ministry of Food and Drug Safety Patent Informatics Project (until 2012)
Hospira Korea product planning consulting
Nebivolol formulation technology transfer contract signed
2011 ~ 2015
Venture company certification
Signed a contract for synthetic research and development of Teneligliptin salt-altered raw materials
Dr.Ready product planning consulting
Tofacitinib salt modified raw material research and development contract
2016 ~ 2020
Signed a Joint development of Tolvaptan Regorafenib
Signed a Joint development of Tolvaptan
Signed a Joint development of Desvenlafaxine
Signed a Joint development of Teneligliptin
Moved the business site (Open M Tower, Gangseo-gu, Seoul)
Acquisition of pharmaceutical import business license
Certified as an excellent company in technology evaluation (Drug development for acquisition of exclusivity)
Certified as an excellent company in technology evaluation (increased new drug research and development technology)
Won the Tower of Export of 1 Million Dollars from the Korea International Trade Association
2021 ~ 2023
Natural product composition patent registration
Signed a contract for the synthesis and development of new improved drugs (domestic synthesis company)
Signed a Joint development of Montelukast complex
Acquisition of drug wholesaler license
Selection and progress of 15 new formulation research items
Signed a contract for the synthesis and development of new improved drugs (Indian synthesis company)
Purchase of R&D center construction site
Inno-Biz Certification
Patent registration for pharmaceutical preparations
Korea International Trade Association Confirmation of export performance of 3 million dollars (2022.07 ~ 2023.06)